Cargando…

Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy

Integrase-defective lentiviral vectors (IDLVs) have been used as a safe and efficient delivery system in several immunization protocols in murine and non-human primate preclinical models as well as in recent clinical trials. In this work, we validated in preclinical murine models our vaccine platfor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morante, Valeria, Borghi, Martina, Farina, Iole, Michelini, Zuleika, Grasso, Felicia, Gallinaro, Alessandra, Cecchetti, Serena, Di Virgilio, Antonio, Canitano, Andrea, Pirillo, Maria Franca, Bona, Roberta, Cara, Andrea, Negri, Donatella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927015/ https://www.ncbi.nlm.nih.gov/pubmed/33672349 http://dx.doi.org/10.3390/v13020355

Ejemplares similares

Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
por: Gallinaro, Alessandra, et al.
Publicado: (2020)

Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization
por: Bona, Roberta, et al.
Publicado: (2021)

Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
por: Gallinaro, Alessandra, et al.
Publicado: (2018)

Persistent immunogenicity of integrase defective lentiviral vectors delivering membrane-tethered native-like HIV-1 envelope trimers
por: Gallinaro, Alessandra, et al.
Publicado: (2022)

Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
por: Rossi, Alessandra, et al.
Publicado: (2014)

Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
por: Borghi, Martina, et al.
Publicado: (2023)

Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
por: Michelini, Zuleika, et al.
Publicado: (2020)

Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
por: Fontana, Judith M., et al.
Publicado: (2014)

Intranasal Administration of Integrase Defective Lentiviral Vectors Expressing mAbs Protects from H5 Influenza Virus Challenge In Vivo
por: Michelini, Zuleika, et al.
Publicado: (2017)

Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
por: Negri, Donatella RM, et al.
Publicado: (2012)

Nonintegrating Lentiviral Vector-Based Vaccine Efficiently Induces Functional and Persistent CD8+ T Cell Responses in Mice
por: Negri, Donatella R. M., et al.
Publicado: (2010)

Simian immunodeficiency virus-Vpx as an adjuvant for integrase defective lentiviral vector-based vaccines
por: Blasi, M, et al.
Publicado: (2012)

Skeletal Muscle Is an Antigen Reservoir in Integrase-Defective Lentiviral Vector-Induced Long-Term Immunity
por: Lin, Yi-Yu, et al.
Publicado: (2020)

Integrase Defective Lentiviral Vector Promoter Impacts Transgene Expression in Target Cells and Magnitude of Vector-Induced Immune Responses
por: Mahesh, Sneha, et al.
Publicado: (2023)

Multivalent interactions essential for lentiviral integrase function
por: Ballandras-Colas, Allison, et al.
Publicado: (2022)

Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency
por: Mariotti, Sabrina, et al.
Publicado: (2021)

Structural Basis for Functional Tetramerization of Lentiviral Integrase
por: Hare, Stephen, et al.
Publicado: (2009)

Seasonal Betacoronavirus Antibodies’ Expansion Post-BNT161b2 Vaccination Associates with Reduced SARS-CoV-2 VoC Neutralization
por: Dispinseri, Stefania, et al.
Publicado: (2022)

Use of Integrase-Minus Lentiviral Vector for Transient Expression
por: Farazmandfar, Touraj, et al.
Publicado: (2012)

The Interaction Between Lentiviral Integrase and LEDGF: Structural and Functional Insights
por: Hare, Stephen, et al.
Publicado: (2009)

Integrase deficient lentiviral vector: prospects for safe clinical applications
por: Yew, Chee-Hong Takahiro, et al.
Publicado: (2022)

Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
por: Taltynov, Oliver, et al.
Publicado: (2012)

Neutralizing antibody responses to SARS-CoV-2 in symptomatic COVID-19 is persistent and critical for survival
por: Dispinseri, Stefania, et al.
Publicado: (2021)

The Lentiviral Integrase Binding Protein LEDGF/p75 and HIV-1 Replication
por: Engelman, Alan, et al.
Publicado: (2008)

Improving the Transduction of Bone Marrow–Derived Cells with an Integrase-Defective Lentiviral Vector
por: Pay, S. Louise, et al.
Publicado: (2018)

New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis
por: Mariotti, Sabrina, et al.
Publicado: (2023)

LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro
por: Cherepanov, Peter
Publicado: (2007)

Hepatocyte-Targeted Expression by Integrase-Defective Lentiviral Vectors Induces Antigen-Specific Tolerance in Mice with Low Genotoxic Risk
por: Mátrai, Janka, et al.
Publicado: (2011)

Strong SARS-CoV-2 N-Specific CD8(+) T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
por: Ferrantelli, Flavia, et al.
Publicado: (2022)

Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
por: Ortinski, Pavel I., et al.
Publicado: (2017)

Antiviral effect of SARS-CoV-2 N-specific CD8(+) T cells induced in lungs by engineered extracellular vesicles
por: Manfredi, Francesco, et al.
Publicado: (2023)

SARS-CoV-2-Specific CD8(+) T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
por: Ferrantelli, Flavia, et al.
Publicado: (2023)

Lentiviral Protein Transduction with Genome-Modifying HIV-1 Integrase-I-PpoI Fusion Proteins: Studies on Specificity and Cytotoxicity
por: Turkki, Vesa, et al.
Publicado: (2014)

Integrase-derived peptides together with CD24-targeted lentiviral particles inhibit the growth of CD24 expressing cancer cells
por: Shapira, Shiran, et al.
Publicado: (2021)

Lentiviral Vector Bioprocessing
por: Perry, Christopher, et al.
Publicado: (2021)

The Inside Out of Lentiviral Vectors
por: Durand, Stéphanie, et al.
Publicado: (2011)

Comparison Between Several Integrase-defective Lentiviral Vectors Reveals Increased Integration of an HIV Vector Bearing a D167H Mutant
por: Qamar Saeed, Muhammad, et al.
Publicado: (2014)

Integrase and integration: biochemical activities of HIV-1 integrase
por: Delelis, Olivier, et al.
Publicado: (2008)

A Novel Co-Crystal Structure Affords the Design of Gain-of-Function Lentiviral Integrase Mutants in the Presence of Modified PSIP1/LEDGF/p75
por: Hare, Stephen, et al.
Publicado: (2009)

HIV-1 integrase inhibitors are substrates for the multidrug transporter MDR1-P-glycoprotein
por: Cianfriglia, Maurizio, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_8a3t0hsvbj5g1ac7vvddhbc0qc